Fluoxetine induced suicidal erythrocyte death

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Fluoxetine, an antidepressant, inhibits acid sphingomyelinase, an enzyme producing ceramide.
• Ceramide induces eryptosis, characterized by erythrocyte shrinkage and phosphatidylserine exposure.
• Eryptosis is linked to increased cytosolic calcium activity ([Ca2+]i).

Purpose of the Study:

• To investigate the effect of fluoxetine on eryptosis in erythrocytes.
• To determine if fluoxetine influences suicidal death in red blood cells.

Main Methods:

• Erythrocytes were exposed to fluoxetine for 48 hours.
• Cell volume was measured by forward scatter.
• Phosphatidylserine exposure was assessed via annexin V binding.
• Hemoglobin release was quantified to detect hemolysis.
• Intracellular calcium ([Ca2+]i) was measured using Fluo-3 fluorescence.

Main Results:

• Fluoxetine exposure (≥25 µM) significantly reduced cell volume (forward scatter).
• Increased phosphatidylserine exposure and elevated [Ca2+]i were observed.
• The effect on phosphatidylserine exposure was partially dependent on extracellular calcium.

Conclusions:

• Fluoxetine stimulates eryptosis in erythrocytes.
• This pro-eryptotic effect is, at least partly, mediated by an increase in cytosolic calcium activity.